Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Phase 2 trial (NEJM 2023) randomized 338 adults with obesity to retatrutide doses from 1 mg to 12 mg/week
No organ damage or immune suppression has been reported at standard research doses
Despite showing clear clinical signs of B12 deficiency, doctors often misdiagnose or ignore these people because their results fall within a good B12 level range
Kainate receptors
Draw your calculated dose using an insulin syringe (for example, 0.20 mL equals 500 mcg at this concentration)
US$ 25.47
US$ 22.44
US$ 25.89
US$ 20.93
